•   
  •   
  •   

Health Pfizer-BioNTech COVID-19 Vaccine Information

03:50  17 january  2021
03:50  17 january  2021 Source:   msn.com

Pfizer’s coronavirus vaccine: Here’s what experts are saying about the new data

  Pfizer’s coronavirus vaccine: Here’s what experts are saying about the new data Although Pfizer's coronavirus vaccine data looks promising, experts say we should remain 'cautious' as the full data has still not been released.The company and its collaborator BioNTech may now be on track to file an emergency use application with U.S. regulators in late November, as previously stated.

Pfizer - BioNTech COVID - 19 Vaccine . (also known as BNT162b2). This product information is intended only for residents of the United States. The Pfizer - BioNTech COVID - 19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized

General Information : Vaccine : Pfizer - BioNTech COVID - 19 Vaccine Diluent: 0.9% sodium chloride (normal saline, preservative-free). Vaccine MUST be mixed with diluent before administration. Multidose vial: Up to 6 doses per vial Dosage: 0.3 mL. Age Indications: 16 years of age and older.

As we all know the federal and provincial governments have quickly passed a vaccine to combat COVID-19. One selected vaccine type will be the Pfizer-BioNTech COVID-19 vaccine, but what do we know about this vaccine?

Traditionally, vaccines take years to develop, test and finally be approved by Health Canada to be used as a vaccine. They usually undergo lab testing, tests on animals then finally human trials to determine the effectiveness and possible adverse side effects long before it is used in the general population.

Lack of testing can bring a lack of public confidence in the safety and protection the vaccine is giving, but with COVID-19 the world has pushed for a vaccine and the vaccine companies feel confident that they have produced a vaccine safe for human use as well as protection against the virus.

What’s Going On with a COVID-19 Vaccine?

  What’s Going On with a COVID-19 Vaccine? Moderna just announced that early data shows its vaccine appears to be 94.5% effective , also based on early data. But don’t book that family reunion for mid-2021 just yet. While it’s certainly news worth celebrating, there are a lot of unknowns about these vaccines and the many others in development—including when they will be widely available. “This news, in my opinion, is a little early,” says Horacio Bach, adjunct professor in the University of British Columbia’s division of infectious diseases, of the Pfizer news last week.

Pfizer and BioNTech are continuing to accumulate safety data and currently estimate that a median of two months of safety data following the Pfizer and BioNTech plan to submit data from the full Phase 3 trial for scientific peer-review publication. About Pfizer : Breakthroughs That Change Patients’ Lives.

Cartons of Pfizer - BioNTech COVID - 19 Vaccine Multiple Dose Vials arrive in thermal containers with dry ice. There is no information on the co-administration of the Pfizer - BioNTech COVID - 19 Vaccine with other vaccines . Information to provide to vaccine recipients/caregivers.

Health Canada authorized the vaccine with conditions on December 9, 2020, under the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.

About the Pfizer-BioNTech COVID-19 Vaccine

The Pfizer-BioNTech COVID-19 mRNA vaccine (Tozinameran or BNT162b2) is used to prevent COVID-19. This disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The vaccine is approved for people who are 16 years of age and older. Its safety and effectiveness in people younger than 16 years of age have not yet been established.

How it works


Video: COVID-19: Are curfews effective at reducing cases? (cbc.ca)

mRNA vaccines teach our cells how to make a protein that will trigger an immune response without using the live virus that causes COVID-19. Once triggered, our body then makes antibodies. These antibodies help us fight the infection if the real virus does enter our body in the future.

If You Live Here, You'll Get the Vaccine First, Says CDC Chief

  If You Live Here, You'll Get the Vaccine First, Says CDC Chief Director of the CDC said that the COVID-19 vaccine would be rolled out by the end of the second week of December, initially in a hierarchical way."First it's exceptional that we have these vaccines and it's very exciting," said Redfield. "And again, it just reinforces why I want people to be vigilant because we're turning the corner." He said the vaccine would be rolled out "probably by the end of the second week of December, initially in a hierarchical way—to nursing home residents, and then some combination of healthcare providers and individuals at high risk for a poor outcome. And those decisions are in the process of being finalized as we speak.

Learn more about how COVID - 19 vaccines work and get a better understanding of COVID - 19 mRNA vaccines . Based on evidence from clinical trials, the Pfizer - BioNTech vaccine was 95% effective at preventing laboratory-confirmed COVID - 19 illness in people without evidence of previous infection.

Recommendations on re- vaccination or additional doses of mRNA COVID - 19 vaccines may be updated as additional information is available. Cases of Bell’s palsy were reported following vaccination in participants in both the Pfizer - BioNTech and Moderna COVID - 19 vaccines clinical

‘RNA’ stands for ribonucleic acid, which is a molecule that provides cells with instructions for making proteins. Messenger RNA (mRNA) vaccines contain the genetic instructions for making the SARS-CoV-2 spike protein. This protein is found on the surface of the virus that causes COVID-19.

When a person is given the vaccine, their cells will read the genetic instructions like a recipe and produce the spike protein. After the protein piece is made, the cell breaks down the instructions and gets rid of them.

The cell then displays the protein piece on its surface. Our immune system recognizes that the protein doesn’t belong there and begins building an immune response and making antibodies.

The side effects that followed vaccine administration in clinical trials were mild or moderate. They included things like pain at the site of injection, body chills, feeling tired and feeling feverish.

These are common side effects of vaccines and do not pose a risk to health.

As with all vaccines, there’s a chance that there will be a serious side effect, but these are rare. A serious side effect might be something like an allergic reaction. Speak with your health professional about any serious allergies or other health conditions you may have before you receive this vaccine.

Health Canada has conducted a rigorous scientific review of the available medical evidence to assess the safety of the Pfizer-BioNTech COVID-19 vaccine. No major safety concerns have been identified in the data that they reviewed.

Gary Horseman, Local Journalism Initiative Reporter, Four-Town Journal

15 Worst Foods Foods for Your Health .
If you have diabetes, heart disease, or high blood pressure, steer clear of these menu items. They're some of the worst fast foods for your health.

usr: 0
This is interesting!